14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.322 $0.440 Friday, 3rd May 2024 GLMD stock ended at $0.387. This is 0.597% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.84% from a day low at $0.367 to a day high of $0.399.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Feb 23, 2023 $0.571 $0.580 $0.550 $0.550 36 819
Feb 22, 2023 $0.579 $0.590 $0.550 $0.571 24 987
Feb 21, 2023 $0.610 $0.650 $0.550 $0.579 63 847
Feb 17, 2023 $0.580 $0.590 $0.580 $0.580 31 060
Feb 16, 2023 $0.580 $0.600 $0.580 $0.583 41 338
Feb 15, 2023 $0.650 $0.650 $0.590 $0.610 46 860
Feb 14, 2023 $0.606 $0.650 $0.601 $0.626 21 746
Feb 13, 2023 $0.620 $0.630 $0.604 $0.610 53 776
Feb 10, 2023 $0.650 $0.650 $0.604 $0.650 10 731
Feb 09, 2023 $0.658 $0.670 $0.610 $0.619 36 114
Feb 08, 2023 $0.662 $0.678 $0.630 $0.678 37 840
Feb 07, 2023 $0.671 $0.724 $0.611 $0.680 300 174
Feb 06, 2023 $0.82 $0.82 $0.650 $0.690 68 206
Feb 03, 2023 $0.740 $0.770 $0.710 $0.710 161 489
Feb 02, 2023 $0.670 $0.745 $0.632 $0.745 183 753
Feb 01, 2023 $0.650 $0.690 $0.620 $0.623 40 550
Jan 31, 2023 $0.583 $0.690 $0.583 $0.661 68 889
Jan 30, 2023 $0.660 $0.660 $0.561 $0.570 127 928
Jan 27, 2023 $0.661 $0.719 $0.650 $0.651 52 693
Jan 26, 2023 $0.656 $0.690 $0.635 $0.671 64 609
Jan 25, 2023 $0.690 $0.712 $0.630 $0.640 102 941
Jan 24, 2023 $0.700 $0.757 $0.690 $0.707 68 899
Jan 23, 2023 $0.730 $0.760 $0.682 $0.716 64 648
Jan 20, 2023 $0.741 $0.772 $0.700 $0.751 85 625
Jan 19, 2023 $0.700 $0.741 $0.652 $0.700 67 900
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT